Infant Formula Containing Beneficial Microbes Will Attain a Market Size of $17.3 Billion, Growing at a CAGR of 28% From $1.45 Billion in 2014, Lux Research Says
BOSTON, MA--(Marketwired - Apr 21, 2015) - Probiotics are poised to storm the infant formula market, with probiotic-containing formula jumping nearly 11-fold in revenue to claim a whopping 76% share of the $22.9 billion market in 2024, according to Lux Research.
Probiotics are live microorganisms that contribute to the population of beneficial microbes in the human gut, which are crucially linked to the proper functioning of the human metabolism. A myriad of probiotics occur naturally in human breast milk and are now thought to have essential functions in the optimal development of infants. In the quest to mimic human breast milk, probiotics have emerged as a vital ingredient of infant formula.
"Probiotics represent an exciting opportunity across diverse markets from infant formula to targeted elderly nutrition and all markets in between," said Camilla Stice, Lux Research Analyst and the lead author of the report titled, "Harnessing the Microbiome for a Better Future: Probiotics Storm the Infant Formula Market."
"Probiotic science and enabling technological developments are evolving rapidly, and developers must stay on top of the latest research so as not to miss crucial discoveries in this fast-moving field," she added.
Lux Research analysts developed a forecasting model for probiotic infant formula over the next decade. Among their findings:
The report, titled "Harnessing the Microbiome for a Better Future: Probiotics Storm the Infant Formula Market," is part of the Lux Research Food and Nutrition Intelligence service.
To hear more on the subject, register for the complimentary webinar, "United we Stand: Harnessing the True Potential of the Microbiome for Health and Wellness," on May 5th at 11:00 EDT.
About Lux Research
Lux Research provides strategic advice and ongoing intelligence for emerging technologies. Leaders in business, finance and government rely on us to help them make informed strategic decisions. Through our unique research approach focused on primary research and our extensive global network, we deliver insight, connections and competitive advantage to our clients. Visit www.luxresearchinc.com for more information.
Contact Information:
Contact:
Carole Jacques
Lux Research, Inc.
617-502-5314
carole.jacques@luxresearchinc.com